Posts tagged with the keyword: ‘Novartis’

European Pharmaceutical Giant Novartis Settles False Claims Act Whistleblower … – The National Law Review

European Pharmaceutical Giant Novartis Settles False Claims Act Whistleblower ... - The National Law Review

European Pharmaceutical Giant Novartis Settles False Claims Act Whistleblower … – The National Law Review In recent years, the laws of the United States have undergone a whistleblower revolution. Federal and state governments now offer substantial monetary awards to individuals who come forward with information about fraud on government programs, tax fraud, securities fraud, and […]

With Big Pharma In Retreat, Ackman And Novartis Try A New Blueprint For Drug … – Forbes

With Big Pharma In Retreat, Ackman And Novartis Try A New Blueprint For Drug ... - Forbes

With Big Pharma In Retreat, Ackman And Novartis Try A New Blueprint For Drug … – Forbes With Big Pharma In Retreat, Ackman And Novartis Try A New Blueprint For Drug Companies – Forbes Log in with your social account: Or, you can log in or sign up using Forbes.

Why You Need To Watch Novartis, Pfizer, Teva Pharmaceutical, and Ariad … – Motley Fool

Why You Need To Watch Novartis, Pfizer, Teva Pharmaceutical, and Ariad ... - Motley Fool

Why You Need To Watch Novartis, Pfizer, Teva Pharmaceutical, and Ariad … – Motley Fool Although we don’t believe in timing the market or panicking over market movements, we do like to keep an eye on big changes — just in case they’re material to our investing thesis. Good morning, fellow Foolish investors! Let’s take […]

Novartis wins a record breakthrough therapy designation for orphan drug – FierceBiotech

Novartis wins a record breakthrough therapy designation for orphan drug – FierceBiotech CHANNELS Novartis wins a record breakthrough therapy designation for orphan drugFierceBiotechNovartis picked up its third breakthrough therapy designation from the FDA, a coveted record number of programs in the Big Pharma crowd. The agency tapped BYM338 (bimagrumab), an antibody developed in collaboration with […]

Novartis muscle wasting drug gets ‘breakthrough’ status – Reuters

Novartis muscle wasting drug gets ‘breakthrough’ status – Reuters Economic Times Novartis muscle wasting drug gets 'breakthrough' statusReutersZURICH | Tue Aug 20, 2013 1:36am EDT. ZURICH (Reuters) – Novartis said on Thursday U.S. regulators have granted breakthrough therapy status for its investigational compound bimagrumab for the potential treatment of patients with sporadic inclusion …Novartis Gets FDA […]

    Copyright 2011-2013, www.EHealthJournal.net, Web Site Development & SEO by SecondEffort, Inc.